Niagen (NAGE) - שווי החברה ברכישה מלאה

Chromadex Corp (NAGE) is recognized as a leading expert in anti-aging components, as evidenced by the market valuation reflected in the price chart, where the indicator stands at 133.41. The brand develops high-tech longevity products and supplements, leveraging patent protection and proven safety. The business is expanding its influence through alliances with global research centers, supplying key raw materials for production to third-party brands.

Enterprise value determines the objective buyout price of a business, accounting for all liabilities. By analyzing the market value of the business net of debt, an investor identifies the real entry threshold. This metric aggregates market capitalization and debt, minus available cash. For Chromadex Corp (NAGE), this metric is critical when assessing the efficiency of its licensing model. The scalability of biotechnologies allows for value growth without capital expenditures in retail.